Predictive value of bone scintigraphy for the detection of joint involvement in XXXX : Dermatologists' perspectives.

@entity1 @entity32 @entity625 @entity4 @entity32621 @entity195 @entity4841 @entity16913
BACKGROUND: @entity195 ( @entity195 ) is a multisystemic @entity32 with @entity16913 . Non-specific @entity4841 without objective signs of @entity625 , such as @entity4 , is common in such @entity1 . Thus, an accurate diagnosis of joint involvement may be challenging for dermatologists. OBJECTIVES: To evaluate the validity of @entity32621 ( @entity32621 ) bone scintigraphy for joint involvement assessment in @entity1 with @entity195 . MATERIALS AND METHODS: In 211 @entity1 with @entity195 who had scintigraphic evaluations due to joint symptoms, agreement between bone scintigraphy findings and clinically evaluated joint complaints was retrospectively assessed using Cohen's kappa (k) statistic. A @entity1 subset (n  =  104) showing agreement between joint complaints and scintigraphy results was re-evaluated by a rheumatologist to determine the level of diagnostic specificity attained by combining bone scintigraphy with clinical examinations of dermatologists. RESULTS: The total kappa value (211 @entity1 ) was 0.604, indicating fair agreement between joint complaints and scintigraphy results. Individual analysis of eleven joint categories revealed statistically significant correlations for wrist (k  =  0.677), shoulder (k  =  0.661), and foot joints (k  =  0.618). Of the 104 referrals to a rheumatologist, 95 (91.34%) were confirmed as having @entity195 -associated @entity16913 . Joint acral areas (e.g., foot, hand, wrist and shoulder) that had the highest kappa value correlations also ranked highest in diagnostic specificity. CONCLUSION: Bone scintigraphy presents a simple and useful option for dermatologists to assess joint involvement in @entity195 @entity1 , especially for specific anatomic sites.
